Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Y Kim

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Brachytherapy|February 8, 2007
Biochemical disease-free survival rates following definitive low-dose-rate prostate brachytherapy with dose escalation to biologic target volumes identified with SPECT/CT capromab pendetideRodney J Ellis, Hang Zhou, Edward Y Kim, et al.
Biochemistry|September 1, 2018
Abietane-Type Diterpenoids Inhibit Protein Tyrosine Phosphatases by Stabilizing an Inactive Enzyme ConformationMichael K Hjortness, Laura Riccardi, Akarawin Hongdusit, et al.
Clinical and Translational Radiation Oncology|August 8, 2025
Simultaneous integrated boost and protection proton beam therapy approach for hepatocellular carcinomaKanokphorn Thonglert, Matthew D Greer, Stephanie K Schaub, et al.
Technology in Cancer Research & Treatment|August 3, 2018
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and ControversiesStephanie K Schaub, Pehr E Hartvigson, Michael I Lock, et al.
Brachytherapy|July 6, 2021
Intravascular coronary brachytherapy combined with a drug-coated balloonKathleen E Kearney, Kent Wallner, Minsun Kim, et al.
Clinical Orthopaedics and Related Research|October 14, 2021
Is Chemotherapy Associated with Improved Overall Survival in Patients with Dedifferentiated Chondrosarcoma? A SEER Database AnalysisLee D Cranmer, Bonny Chau, Jose G Mantilla, et al.
American Journal of Clinical Oncology|March 2, 2026
A Phase 1 Study of Neoadjuvant Cabozantinib in Combination With Radiation Therapy for Sarcomas of the ExtremitiesHannah R Abrams, Elizabeth T Loggers, Michael J Wagner, et al.
Biotechnology for Biofuels|July 4, 2013
Addition of a carbohydrate-binding module enhances cellulase penetration into cellulose substratesVimalier Reyes-Ortiz, Richard A Heins, Gang Cheng, et al.
Advances in Radiation Oncology|April 24, 2019
MRI Radiomic Features Are Independently Associated With Overall Survival in Soft Tissue SarcomaMatthew B Spraker, Landon S Wootton, Daniel S Hippe, et al.
Journal of Palliative Medicine|April 28, 2012
ACR Appropriateness Criteria® non-spine bone metastases, Stephen T Lutz, Simon Shek-Man Lo, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Brachytherapy|February 8, 2007
Biochemical disease-free survival rates following definitive low-dose-rate prostate brachytherapy with dose escalation to biologic target volumes identified with SPECT/CT capromab pendetideRodney J Ellis, Hang Zhou, Edward Y Kim, et al.
Biochemistry|September 1, 2018
Abietane-Type Diterpenoids Inhibit Protein Tyrosine Phosphatases by Stabilizing an Inactive Enzyme ConformationMichael K Hjortness, Laura Riccardi, Akarawin Hongdusit, et al.
Clinical and Translational Radiation Oncology|August 8, 2025
Simultaneous integrated boost and protection proton beam therapy approach for hepatocellular carcinomaKanokphorn Thonglert, Matthew D Greer, Stephanie K Schaub, et al.
Technology in Cancer Research & Treatment|August 3, 2018
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and ControversiesStephanie K Schaub, Pehr E Hartvigson, Michael I Lock, et al.
Brachytherapy|July 6, 2021
Intravascular coronary brachytherapy combined with a drug-coated balloonKathleen E Kearney, Kent Wallner, Minsun Kim, et al.
Clinical Orthopaedics and Related Research|October 14, 2021
Is Chemotherapy Associated with Improved Overall Survival in Patients with Dedifferentiated Chondrosarcoma? A SEER Database AnalysisLee D Cranmer, Bonny Chau, Jose G Mantilla, et al.
American Journal of Clinical Oncology|March 2, 2026
A Phase 1 Study of Neoadjuvant Cabozantinib in Combination With Radiation Therapy for Sarcomas of the ExtremitiesHannah R Abrams, Elizabeth T Loggers, Michael J Wagner, et al.
Biotechnology for Biofuels|July 4, 2013
Addition of a carbohydrate-binding module enhances cellulase penetration into cellulose substratesVimalier Reyes-Ortiz, Richard A Heins, Gang Cheng, et al.
Advances in Radiation Oncology|April 24, 2019
MRI Radiomic Features Are Independently Associated With Overall Survival in Soft Tissue SarcomaMatthew B Spraker, Landon S Wootton, Daniel S Hippe, et al.
Journal of Palliative Medicine|April 28, 2012
ACR Appropriateness Criteria® non-spine bone metastases, Stephen T Lutz, Simon Shek-Man Lo, et al.
Pageof 7